1. Home
  2. PMN vs PLSM Comparison

PMN vs PLSM Comparison

Compare PMN & PLSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$14.08

Market Cap

34.6M

Sector

Health Care

ML Signal

HOLD

PLSM

Pulsenmore Ltd. Ordinary Shares

N/A

Current Price

$3.60

Market Cap

38.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PMN
PLSM
Founded
2004
2014
Country
Canada
Israel
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.6M
38.5M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
PMN
PLSM
Price
$14.08
$3.60
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$42.67
N/A
AVG Volume (30 Days)
40.5K
7.8K
Earning Date
03-25-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.29
$3.43
52 Week High
$27.40
$6.85

Technical Indicators

Market Signals
Indicator
PMN
PLSM
Relative Strength Index (RSI) 33.91 29.05
Support Level $0.41 N/A
Resistance Level $19.85 $4.30
Average True Range (ATR) 2.20 0.39
MACD -0.98 -0.02
Stochastic Oscillator 0.00 10.83

Price Performance

Historical Comparison
PMN
PLSM

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

About PLSM Pulsenmore Ltd. Ordinary Shares

Pulsenmore Ltd is engaged in developing portable ultrasound devices for home use. Its ultrasound scanner dock's with patients' smartphones to deliver images that can be created anywhere, stored and forwarded for clinical review, or shared in an online consultation.

Share on Social Networks: